Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Miklos Pless, Karim Belhadj, Hans D. Menssen, +11

Clinical Cancer Research

Association of Symptomatic Human Infection with Toxoplasma gondii with Imbalance of Monocytes and Antigen-Specific T Cell Subsets

I. Sklenar, Terry C. Jones, Ş. Ş. Alkan, +1

The Journal of Infectious Diseases

Autoimmune DiseaseAllergyTransient Immune DysfunctionGamma InterferonImmunodeficiencies +11

Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.

Salvatore Siena, Marco Bregni, L Bonsi, +4

PubMed

Spontaneous Hypoglycemia Associated With Autoimmunity Specific to Human Insulin

I. Sklenar, Terence J. Wilkin, José-Luis Dı́az, +2

Diabetes Care

A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.

Lillian L. Siu, Eric K. Rowinsky, Lisa A. Hammond, +13

PubMed

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies

Hans‐Heinrich Wolf, S.V. Davies, Michael Borte, +9

Vox Sanguinis

Effect of Various Doses of Intravenous Polyclonal IgG on in vivo Levels of 12 Pneumococcal Antibodies in Patients with Chronic Lymphocytic Leukaemia and Multiple Myeloma

I. Sklenar, Gerald Schiffman, Viggo Jønsson, +19

Oncology

ImmunohematologyImmunologyPathologyCll PatientsImmunophenotyping +17

A Phase Ib and Pharmacokinetic Trial of Patupilone Combined with Carboplatin in Patients with Advanced Cancer

Martin Förster, Stan B. Kaye, Amit M. Oza, +5

Clinical Cancer Research

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy

Alessandro M. Gianni, Salvatore Siena, Marco Bregni, +6

Annals of Oncology

Hematological MalignancyOncologyMedicineMetronomic TherapyImmunology +6

Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer

Kell Østerlind, Juan Manuel Sepúlveda-Sánchez, Petr Zatloukal, +7

Journal of Clinical Oncology

Advanced NsclcMedicineMetronomic TherapyPharmacologyClinical Trials +12